Cargando…
What Can Ribo-Seq, Immunopeptidomics, and Proteomics Tell Us About the Noncanonical Proteome?
Ribosome profiling (Ribo-Seq) has proven transformative for our understanding of the human genome and proteome by illuminating thousands of noncanonical sites of ribosome translation outside the currently annotated coding sequences (CDSs). A conservative estimate suggests that at least 7000 noncanon...
Autores principales: | Prensner, John R., Abelin, Jennifer G., Kok, Leron W., Clauser, Karl R., Mudge, Jonathan M., Ruiz-Orera, Jorge, Bassani-Sternberg, Michal, Moritz, Robert L., Deutsch, Eric W., van Heesch, Sebastiaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506109/ https://www.ncbi.nlm.nih.gov/pubmed/37572790 http://dx.doi.org/10.1016/j.mcpro.2023.100631 |
Ejemplares similares
-
What can Ribo-seq and proteomics tell us about the non-canonical proteome?
por: Prensner, John R., et al.
Publicado: (2023) -
Integrative analysis of macrophage ribo-Seq and RNA-Seq data define glucocorticoid receptor regulated inflammatory response genes into distinct regulatory classes
por: Ansari, Suhail A., et al.
Publicado: (2022) -
Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues
por: Abelin, Jennifer G., et al.
Publicado: (2023) -
Editorial: Immunopeptidomic Approaches for the Identification of Tumor (neo)Antigens
por: Lill, Jennie R., et al.
Publicado: (2022) -
Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγ
por: Newey, Alice, et al.
Publicado: (2023)